BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 223 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $556,855 | -46.7% | 21,984 | -34.9% | 0.08% | -40.6% |
| Q1 2024 | $1,044,292 | +28.6% | 33,774 | +67.9% | 0.13% | -15.8% |
| Q4 2023 | $812,244 | +638.5% | 20,120 | +382.4% | 0.16% | +393.8% |
| Q3 2023 | $109,989 | +203.9% | 4,171 | +98.2% | 0.03% | +190.9% |
| Q2 2023 | $36,189 | +6.5% | 2,104 | +2.6% | 0.01% | -8.3% |
| Q1 2023 | $33,989 | +193.6% | 2,050 | +35.0% | 0.01% | +140.0% |
| Q4 2022 | $11,575 | -17.3% | 1,519 | +9.4% | 0.01% | -16.7% |
| Q3 2022 | $14,000 | – | 1,388 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $373,797,000 | 67.28% |
| Darwin Global Management, Ltd. | 2,090,149 | $128,753,000 | 25.21% |
| Affinity Asset Advisors, LLC | 577,500 | $35,574,000 | 12.08% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $1,913,356,000 | 9.64% |
| Perceptive Advisors | 7,756,928 | $477,827,000 | 6.04% |
| Opaleye Management Inc. | 583,767 | $35,960,000 | 5.28% |
| MIZUHO MARKETS AMERICAS LLC | 171,923 | $10,590,000 | 4.93% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $1,639,853,000 | 4.88% |
| Fernwood Investment Management, LLC | 151,085 | $9,307,000 | 3.42% |
| HHLR ADVISORS, LTD. | 5,362,014 | $330,300,000 | 3.26% |